KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Inventory (2016 - 2025)

Globus Medical's Change in Inventory history spans 15 years, with the latest figure at $178000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 98.5% year-over-year to $178000.0; the TTM value through Dec 2025 reached $17.6 million, down 41.06%, while the annual FY2025 figure was $17.6 million, 41.06% down from the prior year.
  • Change in Inventory reached $178000.0 in Q4 2025 per GMED's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $22.5 million in Q1 2023 to a low of -$4.9 million in Q3 2024.
  • Average Change in Inventory over 5 years is $9.6 million, with a median of $10.2 million recorded in 2023.
  • Peak YoY movement for Change in Inventory: skyrocketed 565.12% in 2022, then plummeted 124.03% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $2.8 million in 2021, then skyrocketed by 366.01% to $13.1 million in 2022, then dropped by 13.33% to $11.4 million in 2023, then grew by 4.73% to $11.9 million in 2024, then tumbled by 98.5% to $178000.0 in 2025.
  • Per Business Quant, the three most recent readings for GMED's Change in Inventory are $178000.0 (Q4 2025), $5.7 million (Q3 2025), and $4.1 million (Q2 2025).